The gateway to the Australian pharmaceutical and medical device market

About TGA – Therapeutic Goods Administration

The Therapeutic Goods Administration (TGA) is the regulatory body of the Australian Government responsible for evaluating, supervising and approving pharmaceutical products, medical devices and other healthcare products before they are allowed to circulate on the Australian market. TGA ensures that all of these products meet stringent safety, efficacy, and quality standards to protect public health.

In addition to acting as a regulatory body, TGA also provides training, consulting and certification services to support businesses, organizations and individuals in the process of developing, registering and operating products in the Australian market.

TGA Training Services

TGA organizes a variety of training programs, from basic to advanced, for subjects such as manufacturers, distributors, medical experts, researchers and organizations related to the field of pharmaceuticals and medical devices. These trainings are typically designed to:

• Provide in-depth knowledge of the current legal regulations related to medicines, medical devices, supplements, biologicals, in vitro diagnostics and cosmetic products in Australia.
• Guiding the process of filing, evaluating and approving products according to TGA standards.
• Raise awareness of product safety, risk management, and after-sales monitoring processes.
• Training on quality management systems, GxP STANDARDS (GMP, GDP, GCP, GLP) and related international standards.
• Stay up to date with the latest changes in TGA’s health management regulations and policies.

The courses often combine theory and practice, using real-life situations, group exercises, and simulations of the product registration process to give students a comprehensive, practical view. In particular, TGA also organizes online seminars, training programs according to the specific requirements of businesses as well as in-depth courses for each specific product field group.

TGA Consulting Services

TGA and its authorized partners provide comprehensive consulting services to businesses and organizations wishing to bring their products to the Australian market or ensure compliance with TGA regulations. The contents of the consultation include:

• Analyze and evaluate the legality and appropriate roadmap for products to meet TGA standards.
• Assisting in developing product registration strategies, preparing dossiers, scientific evidence, technical documents, and supporting communication with regulators.
• Evaluate the internal quality management system, support improvement to meet GMP (Good Manufacturing Practice) standards or other relevant certifications.
• Advising on issues related to product changes, risk management, safety warnings, product recalls, and medical incident reporting.
• Guide enterprises to solve problems in the process of post-inspection, periodic inspection or when inspected by TGA.
• Train and build the capacity of personnel to meet quality control requirements and comply with legal regulations.

In addition, the consultant also supports businesses in market research, identifies opportunities and challenges, optimizes product commercialization roadmaps in Australia, thereby minimizing risks and development costs.

TGA Certification Services

In order for a pharmaceutical product, medical device or other healthcare product to be allowed to circulate on the Australian market, the product owner must comply with the TGA’s strict certification process. TGA’s certification services include:

• Legality checks, document checks, and comprehensive evaluations of product safety, efficacy, and quality.
• Carry out tests, technical verifications, production process inspections, and clinical trials (if necessary).
• Evaluate and inspect the quality management system of the enterprise according to GMP standards or appropriate ISO standards.
• Appraisal and issuance of ARTG (Australian Register of Therapeutic Goods) codes for standard products, allowing them to be legally circulated in Australia.
• After-sales supervision, periodic inspection, and handling of problems arising during product circulation on the market.

The TGA certification process often consists of many complex steps, requiring close coordination between businesses, consulting organizations and regulatory agencies. Obtaining certification from the TGA not only helps the product reach the Australian market but also improves its reputation and expands export opportunities to other international markets.

Benefits of TGA training, consulting and certification services

Participating in and successfully meeting the TGA training, consulting and certification processes brings many practical benefits to businesses and organizations:

• Improve knowledge and capacity to comply with the law in the Australian market.
• Quickly and effectively access the large and potential pharmaceutical and medical device markets.
• Minimize legal, financial and reputational risks during product commercialization.
• Improve brand value, reputation and trust of partners and consumers in Australia and internationally.
• Increase the ability to transfer technology and international cooperation by meeting the high standards of the TGA.
• Optimize the product development process, save time and costs thanks to a clear roadmap.

Product registration and certification process with TGA

To register and certify products according to TGA regulations, businesses need to take the following basic steps:

• Assess the conformity and determine the type of product according to the classification of the TGA (drugs, medical devices, biologicals, cosmetics, etc.)
• Prepare and complete a set of technical documents, scientific documents, evidence of product safety and effectiveness.
• Submit the registration dossier to the TGA’s online system, and pay the appraisal fee as prescribed.
• Wait for reviews, feedback, and additional information if requested.
• Once approved, receive the ARTG number and the product circulation license in Australia.
• Perform after-sales supervision obligations, report incidents (if any) and comply with periodic inspection regulations.

Products in high-risk groups (e.g., implantable medical devices, new drugs, complex biologics) often require preclinical studies, clinical trials, or more in-depth evaluations before being approved for marketing.

The TGA plays a key role in ensuring the safety, quality and effectiveness of healthcare products in Australia. Through training, consulting and certification services, TGA not only supports businesses to access the Australian market but also contributes to improving operational standards, promoting the sustainable development of the pharmaceutical – medical device industry in particular and the healthcare sector in general.

Understanding and complying with TGA regulations, as well as effectively utilizing related support services, will be the key for businesses and organizations to achieve success, expand their scope of operations and affirm their position in today’s competitive international market.